GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (BOM:532331) » Definitions » Shiller PE Ratio

Ajanta Pharma (BOM:532331) Shiller PE Ratio : 48.01 (As of May. 15, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma Shiller PE Ratio?

As of today (2024-05-15), Ajanta Pharma's current share price is ₹2437.55. Ajanta Pharma's E10 for the quarter that ended in Mar. 2024 was ₹50.77. Ajanta Pharma's Shiller PE Ratio for today is 48.01.

The historical rank and industry rank for Ajanta Pharma's Shiller PE Ratio or its related term are showing as below:

BOM:532331' s Shiller PE Ratio Range Over the Past 10 Years
Min: 23.51   Med: 29.44   Max: 46.82
Current: 46.79

During the past years, Ajanta Pharma's highest Shiller PE Ratio was 46.82. The lowest was 23.51. And the median was 29.44.

BOM:532331's Shiller PE Ratio is ranked worse than
79.59% of 534 companies
in the Drug Manufacturers industry
Industry Median: 25.25 vs BOM:532331: 46.79

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ajanta Pharma's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹16.090. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹50.77 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ajanta Pharma Shiller PE Ratio Historical Data

The historical data trend for Ajanta Pharma's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma Shiller PE Ratio Chart

Ajanta Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 24.21 44.08

Ajanta Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.21 28.49 34.58 38.89 44.08

Competitive Comparison of Ajanta Pharma's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Ajanta Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ajanta Pharma's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ajanta Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ajanta Pharma's Shiller PE Ratio falls into.



Ajanta Pharma Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ajanta Pharma's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=2437.55/50.77
=48.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ajanta Pharma's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Ajanta Pharma's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=16.09/153.2548*153.2548
=16.090

Current CPI (Mar. 2024) = 153.2548.

Ajanta Pharma Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 4.520 94.103 7.361
201409 6.287 96.780 9.956
201412 7.047 96.780 11.159
201503 5.613 97.163 8.853
201506 6.513 99.841 9.997
201509 7.833 101.753 11.798
201512 8.633 102.901 12.858
201603 8.253 102.518 12.337
201606 9.053 105.961 13.094
201609 9.900 105.961 14.319
201612 10.793 105.196 15.724
201703 8.633 105.196 12.577
201706 7.180 107.109 10.273
201709 9.987 109.021 14.039
201712 11.173 109.404 15.651
201803 7.160 109.786 9.995
201806 8.013 111.317 11.032
201809 9.500 115.142 12.645
201812 5.067 115.142 6.744
201903 6.733 118.202 8.730
201906 8.760 120.880 11.106
201909 8.887 123.175 11.057
201912 8.213 126.235 9.971
202003 9.867 124.705 12.126
202006 11.287 127.000 13.620
202009 13.000 130.118 15.312
202012 13.607 130.889 15.932
202103 11.953 131.771 13.902
202106 13.390 134.084 15.304
202109 15.100 135.847 17.035
202112 14.770 138.161 16.384
202203 11.700 138.822 12.916
202206 13.630 142.347 14.674
202209 12.220 144.661 12.946
202212 10.500 145.763 11.040
202303 9.540 146.865 9.955
202306 16.530 150.280 16.857
202309 15.500 151.492 15.680
202312 16.670 153.255 16.670
202403 16.090 153.255 16.090

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ajanta Pharma  (BOM:532331) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Ajanta Pharma Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Ajanta Pharma's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ajanta Pharma (BOM:532331) Business Description

Traded in Other Exchanges
Address
Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067
Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma (BOM:532331) Headlines

No Headlines